These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 20406841)
1. Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma. Mengual L; Burset M; Ribal MJ; Ars E; Marín-Aguilera M; Fernández M; Ingelmo-Torres M; Villavicencio H; Alcaraz A Clin Cancer Res; 2010 May; 16(9):2624-33. PubMed ID: 20406841 [TBL] [Abstract][Full Text] [Related]
2. Validation study of a noninvasive urine test for diagnosis and prognosis assessment of bladder cancer: evidence for improved models. Mengual L; Ribal MJ; Lozano JJ; Ingelmo-Torres M; Burset M; Fernández PL; Alcaraz A J Urol; 2014 Jan; 191(1):261-9. PubMed ID: 23831312 [TBL] [Abstract][Full Text] [Related]
3. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction. Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962 [TBL] [Abstract][Full Text] [Related]
4. Novel blood biomarkers of human urinary bladder cancer. Osman I; Bajorin DF; Sun TT; Zhong H; Douglas D; Scattergood J; Zheng R; Han M; Marshall KW; Liew CC Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3374-80. PubMed ID: 16740760 [TBL] [Abstract][Full Text] [Related]
5. DNA microarray expression profiling of bladder cancer allows identification of noninvasive diagnostic markers. Mengual L; Burset M; Ars E; Lozano JJ; Villavicencio H; Ribal MJ; Alcaraz A J Urol; 2009 Aug; 182(2):741-8. PubMed ID: 19539325 [TBL] [Abstract][Full Text] [Related]
6. A molecular signature in superficial bladder carcinoma predicts clinical outcome. Dyrskjøt L; Zieger K; Kruhøffer M; Thykjaer T; Jensen JL; Primdahl H; Aziz N; Marcussen N; Møller K; Orntoft TF Clin Cancer Res; 2005 Jun; 11(11):4029-36. PubMed ID: 15930337 [TBL] [Abstract][Full Text] [Related]
7. Using microRNA profiling in urine samples to develop a non-invasive test for bladder cancer. Mengual L; Lozano JJ; Ingelmo-Torres M; Gazquez C; Ribal MJ; Alcaraz A Int J Cancer; 2013 Dec; 133(11):2631-41. PubMed ID: 23686449 [TBL] [Abstract][Full Text] [Related]
8. [The diagnostic value of microsatellite LOH analysis and the prognostic relevance of angiogenic gene expression in urinary bladder cancer]. Szarvas T Magy Onkol; 2009 Dec; 53(4):385-9. PubMed ID: 20071311 [TBL] [Abstract][Full Text] [Related]
9. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma. Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193 [TBL] [Abstract][Full Text] [Related]
10. Utility of urothelial mRNA markers in blood for staging and monitoring bladder cancer. Marín-Aguilera M; Mengual L; Ribal MJ; Ars E; Ríos J; Gázquez C; Villavicencio H; Alcaraz A Urology; 2012 Jan; 79(1):240.e9-15. PubMed ID: 22055693 [TBL] [Abstract][Full Text] [Related]
11. Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Dyrskjøt L; Kruhøffer M; Thykjaer T; Marcussen N; Jensen JL; Møller K; Ørntoft TF Cancer Res; 2004 Jun; 64(11):4040-8. PubMed ID: 15173019 [TBL] [Abstract][Full Text] [Related]
12. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Urakami S; Shiina H; Enokida H; Kawakami T; Kawamoto K; Hirata H; Tanaka Y; Kikuno N; Nakagawa M; Igawa M; Dahiya R Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2109-16. PubMed ID: 16609023 [TBL] [Abstract][Full Text] [Related]
13. Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR. Guo B; Luo C; Xun C; Xie J; Wu X; Pu J Exp Oncol; 2009 Mar; 31(1):43-7. PubMed ID: 19300416 [TBL] [Abstract][Full Text] [Related]
14. Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder. Holyoake A; O'Sullivan P; Pollock R; Best T; Watanabe J; Kajita Y; Matsui Y; Ito M; Nishiyama H; Kerr N; da Silva Tatley F; Cambridge L; Toro T; Ogawa O; Guilford P Clin Cancer Res; 2008 Feb; 14(3):742-9. PubMed ID: 18245534 [TBL] [Abstract][Full Text] [Related]
15. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection. Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682 [TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder. Wild PJ; Herr A; Wissmann C; Stoehr R; Rosenthal A; Zaak D; Simon R; Knuechel R; Pilarsky C; Hartmann A Clin Cancer Res; 2005 Jun; 11(12):4415-29. PubMed ID: 15958626 [TBL] [Abstract][Full Text] [Related]
17. A candidate molecular signature associated with tamoxifen failure in primary breast cancer. Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543 [TBL] [Abstract][Full Text] [Related]
18. A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis. Rouprêt M; Hupertan V; Yates DR; Comperat E; Catto JW; Meuth M; Lackmichi A; Ricci S; Lacave R; Gattegno B; Richard F; Hamdy FC; Cussenot O BJU Int; 2008 Jun; 101(11):1448-53. PubMed ID: 18325051 [TBL] [Abstract][Full Text] [Related]
19. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer. Yu J; Zhu T; Wang Z; Zhang H; Qian Z; Xu H; Gao B; Wang W; Gu L; Meng J; Wang J; Feng X; Li Y; Yao X; Zhu J Clin Cancer Res; 2007 Dec; 13(24):7296-304. PubMed ID: 18094410 [TBL] [Abstract][Full Text] [Related]
20. Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer. Eissa S; Swellam M; Shehata H; El-Khouly IM; El-Zayat T; El-Ahmady O J Urol; 2010 Feb; 183(2):493-8. PubMed ID: 20006858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]